Jennifer Domico

TL;DR: Estimated ischaemic core volume was independently associated with functional independence and functional improvement but did not modify the treatment benefit of endovascular thrombectomy over standard medical therapy for improved functional outcome.

TL;DR: A current estimated annual thrombectomy rate of three procedures per 100 000 people indicates significant potential increase in the volume of endovascular procedures and the need to develop systems of care.

TL;DR: There was no statistically significant difference in long-term survival when ER patients are compared with LR patients or when patients who had received emergent HD were compared with those who had not, and the financial costs of emergentHD alone merit greater promotion of ER and the psychosocial preparation and modality choice it allows.

TL;DR: The use of the neutrophil–lymphocyte ratio, a readily available biomarker, may be a clinically useful tool for risk stratification when evaluating AIS patients as candidates for endovascular therapies.

TL;DR: These studies suggest NO production is low in patients with ESRD undergoing HD, possibly because of the increased ratio of plasma ADMA to arginine.